Defining the Failure of Medical Therapy for Inflammatory Bowel Disease in the Era of Advanced Therapies: A Systematic Review
Author:
Affiliation:
1. Department 5, Internal Medicine—Gastroenterology, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania
2. Colentina Clinical Hospital, 020125 Bucharest, Romania
3. Emergency University Hospital, 050098 Bucharest, Romania
Abstract
Publisher
MDPI AG
Subject
General Biochemistry, Genetics and Molecular Biology,Medicine (miscellaneous)
Link
https://www.mdpi.com/2227-9059/11/2/544/pdf
Reference42 articles.
1. Addition of azathioprine to the switch of anti-TNF in patients with IBD in clinical relapse with undetectable anti-TNF trough levels and antidrug antibodies: A prospective randomised trial;Roblin;Gut,2020
2. Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis;Sands;N. Engl. J. Med.,2019
3. Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis;Sandborn;N. Engl. J. Med.,2017
4. Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis;Rutgeerts;N. Engl. J. Med.,2005
5. Adalimumab Induces and Maintains Clinical Remission in Patients with Moderate-to-Severe Ulcerative Colitis;Sandborn;Gastroenterology,2012
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Inflammatory Bowel Disease: A Comprehensive Analysis of Molecular Bases, Predictive Biomarkers, Diagnostic Methods, and Therapeutic Options;International Journal of Molecular Sciences;2024-06-27
2. Approach to loss of response to advanced therapies in inflammatory bowel disease;World Journal of Gastroenterology;2024-06-14
3. Immunogenicity and Loss of Effectiveness of Biologic Therapy for Inflammatory Bowel Disease Patients Due to Anti-Drug Antibody Development;Antibodies;2024-02-26
4. Safety, Efficacy and Persistence of Advanced Therapies in Inflammatory Bowel Disease: Results from ORIGINS. A Retrospective Observational Study;Journal of Gastrointestinal and Liver Diseases;2023-12-22
5. Editorial: Novel Therapeutic Approaches in Inflammatory Bowel Diseases;Biomedicines;2023-09-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3